Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis

被引:3
|
作者
Bond, A
Corlett, L
Nagvekar, N
Jacobson, L
Pantic, N
Beeson, D
Nicolle, M
Vincent, A
NewsomDavis, J
Spack, E
Willcox, N
机构
[1] JOHN RADCLIFFE HOSP,INST MOL MED,NEUROSCI GRP,OXFORD OX3 9DU,ENGLAND
[2] ANERGEN,DEPT IMMUNOL,REDWOOD CITY,CA 94063
关键词
D O I
10.1042/bst0250665
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:665 / 670
页数:6
相关论文
共 50 条
  • [21] Specific immunotherapy of experimental myasthenia gravis in vitro:: The "guided missile" strategy
    Wu, JM
    Wu, B
    Miagkov, A
    Adams, RN
    Drachman, DB
    CELLULAR IMMUNOLOGY, 2001, 208 (02) : 137 - 147
  • [22] Immunotherapy with alloreactive T-cells?
    Madrigal, AJ
    Rusakiewiez, S
    Dodi, AI
    Rees, R
    HEMATOLOGY JOURNAL, 2004, 5 : S91 - S95
  • [23] Immunotherapy with γδ T-cells: the future is there
    Kabelitz, Dieter
    Yin, Zhinan
    IMMUNOTHERAPY, 2024, 16 (11) : 705 - 708
  • [24] EFFECT OF THYMECTOMY ON CHANGES IN T-CELLS AND B-CELLS OF PERIPHERAL-BLOOD IN MYASTHENIA-GRAVIS
    SEN, L
    FINIASZ, M
    ESTEVEZ, ME
    OLMEDO, G
    HERRERA, M
    MEDICINA-BUENOS AIRES, 1978, 38 (06) : 808 - 809
  • [25] Antigen specific B cells in myasthenia gravis patients
    Takata, Kazushiro
    Kinoshita, Makoto
    Mochizuki, Hideki
    Okuno, Tatsusada
    IMMUNOLOGICAL MEDICINE, 2020, 43 (02) : 65 - 71
  • [26] Current and future immunotherapy in myasthenia gravis
    Katzberg, Hans D.
    Bril, Vera
    FUTURE NEUROLOGY, 2009, 4 (06) : 745 - 759
  • [27] Immunotherapy in myasthenia gravis in the era of biologics
    Dalakas, Marinos C.
    NATURE REVIEWS NEUROLOGY, 2019, 15 (02) : 113 - 124
  • [28] Immunotherapy in myasthenia gravis in the era of biologics
    Marinos C. Dalakas
    Nature Reviews Neurology, 2019, 15 : 113 - 124
  • [29] Clinical heterogeneity of seronegative myasthenia gravis
    Evoli, A
    Batocchi, AP
    LoMonaco, M
    Servidei, S
    Padua, L
    Majolini, L
    Tonali, P
    NEUROMUSCULAR DISORDERS, 1996, 6 (03) : 155 - 161
  • [30] Immunotherapy of malignant pleural mesothelioma using MET specific T-cells
    Thayaparan, T.
    Van der Stegen, S.
    Pereira, A. Parente
    Petrovic, R.
    Spicer, J.
    Maher, J.
    LUNG CANCER, 2014, 83 : S28 - S28